ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global le

First Robotic Magnetic Navigation system installed in Hungary University of Szeged, led by Cardiolog

Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-

ST. LOUIS and ROUEN, France, July 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer a

Stereotaxis NYSEAMERICAN: STXS said its first-quarter results did not yet reflect what management de

Piper Sandler analyst Adam Maeder reiterates Stereotaxis (AMEX:STXS) with a Overweight and lowers

Stereotaxis, Inc. (STXS) Q1 2026 Earnings Call Transcript

Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.06) per share which missed the analyst cons

Proprietary robotically-navigated MAGiC catheter received U. S. FDA approval in January and is now b

STXS stock gains after first U.S. MAGiC procedures, marking a key milestone in robotic cardiac care

ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader

ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader

Stereotaxis expands in robotic surgery with Robocath acquisition, aiming to build a comprehensive en

Stereotaxis, Inc. (STXS) M&A Call Transcript

Stereotaxis to acquire Robocath, advancing robotic endovascular tech and accelerating expansion into

This acquisition significantly strengthens Stereotaxis' position as a leading platform for the f

ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer

STXS jumps on FDA clearance of Synchrony system, a 4K platform integrating cath lab tech with cloud

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive end

ST. LOUIS, April 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader

Stereotaxis targets early-stage endovascular robotics with differentiated magnetic navigation for el

Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript

Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.06 per share in line with the Zacks Con

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for it

  During Thursday, 849 stocks hit new 52-week lows.

    Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs.

Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Monday